It has been noted that orders are flowing regularly for the consulting and outsourcing company Accenture Plc. (ACN). The company has regularly won orders; the recent addition is a deal from The Phoenix Partnership (“TPP”). Accenture is required to deploy patient administration system for the National Health Services (“NHS”) in southern England, across nine community health systems.
The multi-million dollar agreement will see the collaboration of Accenture and TPP to create a single electronic patient record system. This deployment will help clinicians to assess and exchange health information throughout the healthcare community.
Accenture will partner the Trusts in Southern Community & Child Health Procurement consortium for the implementation of the TPP SystmOne solution. Additionally, Accenture will provide support for integrating, hosting and deployment of the applications for the solution.
Moreover, Accenture will also assist TPP in adding up capabilities into the SystmOne platform such as e-prescribing, to support community services, community hospitals, minor injury management units and child health related issues.
Now the EHR is gaining ground across the globe and most of the healthcare companies and medical organizations have been adopting this new technology. Some of the government departments are taking the help of Electronic medical records, in order to rationalize health care costs, and help the doctors treat patients efficiently.
Also, an interim survey by the outsourcing and consulting services provider reveals that demand for Accenture’s services from some healthcare companies are increasing. We believe that the opportunity will prove beneficial for Accenture’s revenue growth.
Though this is encouraging, we believe similar product offerings from the likes of Dell Inc (DELL) and International Business Machines Corp. (IBM) are concerns.
Currently, Accenture has a Zacks #3 Rank (Hold).
ACCENTURE PLC (ACN): Free Stock Analysis Report
DELL INC (DELL): Free Stock Analysis Report
INTL BUS MACH (IBM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment